Facebook
X
LinkedIn
Forward
68th Annual Scientific Meeting Pre-Course 3: Refractory Headache: Diagnostic and Management Challenges Across Headache Disorders
Course Instructions
- AHS members have complimentary access to the recorded content within this course. All others should create a new visitor account or login as a visitor to purchase the course.
- Once logged in or purchased, click "Take course" to access recorded content, complete the meeting evaluation, claim CME, and download a certificate.
Target Audience
The Annual Scientific Meeting is designed for physicians, psychologists, scientists, researchers, physician assistants, nurse practitioners, and other health professionals involved in the care of patients with head, neck, and orofacial pain.
Learning Objectives
At the conclusion of the program, participants will report their intention to:
- Evaluate risk factors, contributors, and pathophysiology for refractory headache across a range of headache disorders
- Review diagnostic considerations for individuals with refractory headache across a range of headache disorders
- Describe a multimodal therapeutic approach to management of individuals with refractory headache
- Assess current and emerging therapeutic targets
Disclosure Information
The planners and faculty for this activity did not have any relationships to disclose unless listed below. All relevant relationships were mitigated prior to the start of the activity according to ACCME Standards.
PURPOSE/OBJECTIVE
Following this CME activity, learners will report improved competence in recognizing, classifying, and managing refractory headache disorders—including pressure-related syndromes (high, low, and mixed), post-traumatic headache, cluster headache, and refractory migraine—by contextualizing diagnostic and therapeutic strategies across emergency, inpatient, and outpatient settings. Learners will demonstrate improved performance by applying evidence-based, multidisciplinary management frameworks to real-world clinical decision-making, reducing variability in care and overcoming common barriers such as diagnostic uncertainty, fragmented care pathways, and escalation of treatment in complex cases. As a result, this activity is designed to improve patient outcomes by promoting more timely diagnosis, appropriate escalation or de-escalation of therapies, coordinated multidisciplinary care, and improved symptom control for patients with refractory and high-burden headache disorders.
ACCREDITATION STATEMENT
The American Headache Society® is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CREDIT DESIGNATION STATEMENT
The American Headache Society® designates this enduring material for a maximum of 2.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
INSTRUCTIONS FOR CLAIMING CME:
- Login/create a new visitor account (when creating an account, please be sure to use the email address you used during registration for the Annual Scientific Meeting).
- Watch the session recording.
- Complete the post-activity evaluation.
- Enter the number of CME credits being claimed*.
- Download your certificate.
*Please note: The maximum number of credits is calculated based on watching the entire session recording.
FINANCIAL DISCLOSURES
The planners and faculty for this activity did not have any relationships to disclose unless listed here. All relevant relationships were mitigated prior to the start of the activity according to ACCME Standards.
DISCLOSURE OF COMMERCIAL SUPPORT
The American Headache Society® received funding for the in-person 68th Annual Scientific Meeting from the following organizations:
AbbVie Inc
Axsome Therapeutics, Inc.
Lundbeck LLC
Pfizer Inc
BIBLIOGRAPHY
References are available within the session recording.
Available Credit
- 2.00 AMA PRA Category 1 Credit™
- 2.00 Participation
